TPX2 and clear cell renal carcinoma: TPX2, a microtubule-associated protein, is overexpressed in metastatic hepatocellular carcinoma and clear cell renal cell carcinoma (44, 45), underscoring its potential as both a biomarker and therapeutic target in aggressive tumors.